Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Chou

Showing results (361-370 of 375) with videos related to

Pageof 38
Sort By:
Oncogene|August 1, 2017
EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasisC-H Shih, Y-J Chang, W-C Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2018
A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid LeukemiaTimothy S Pardee, Rebecca G Anderson, Kristin M Pladna, et al.
Science (New York, N.Y.)|March 8, 2008
Frequency ratio of Al+ and Hg+ single-ion optical clocks; metrology at the 17th decimal placeT Rosenband, D B Hume, P O Schmidt, et al.
Journal of the American Society of Nephrology : JASN|November 9, 2016
<i>APOL1</i> Renal-Risk Variants Induce Mitochondrial DysfunctionLijun Ma, Jeff W Chou, James A Snipes, et al.
Frontiers in Oncology|December 27, 2021
Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor OutcomesAshok K Pullikuth, Eric D Routh, Kip D Zimmerman, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|March 12, 2013
Taiwan aneurysm registry: multivariate analysis of two-month, one-year, and two-year outcomes after endovascular and microsurgical treatment of ruptured aneurysmsH-M Liu, H-F Wong, K-W Lee, et al.
Oncoimmunology|November 3, 2018
Tumor mutational burden is a determinant of immune-mediated survival in breast cancerAlexandra Thomas, Eric D Routh, Ashok Pullikuth, et al.
The Pharmacogenomics Journal|August 3, 2010
Genomic indicators in the blood predict drug-induced liver injuryJ Huang, W Shi, J Zhang, et al.
Scientific Reports|July 14, 2017
Next Generation Driver for Attosecond and Laser-plasma PhysicsD E Rivas, A Borot, D E Cardenas, et al.
Kidney International Reports|June 11, 2020
<i>APOL1</i> Kidney-Risk Variants Induce Mitochondrial FissionLijun Ma, Hannah C Ainsworth, James A Snipes, et al.
Pageof 38

Showing results (361-370 of 375) with videos related to

Sort By:
Pageof 38
Oncogene|August 1, 2017
EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasisC-H Shih, Y-J Chang, W-C Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2018
A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid LeukemiaTimothy S Pardee, Rebecca G Anderson, Kristin M Pladna, et al.
Science (New York, N.Y.)|March 8, 2008
Frequency ratio of Al+ and Hg+ single-ion optical clocks; metrology at the 17th decimal placeT Rosenband, D B Hume, P O Schmidt, et al.
Journal of the American Society of Nephrology : JASN|November 9, 2016
<i>APOL1</i> Renal-Risk Variants Induce Mitochondrial DysfunctionLijun Ma, Jeff W Chou, James A Snipes, et al.
Frontiers in Oncology|December 27, 2021
Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor OutcomesAshok K Pullikuth, Eric D Routh, Kip D Zimmerman, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|March 12, 2013
Taiwan aneurysm registry: multivariate analysis of two-month, one-year, and two-year outcomes after endovascular and microsurgical treatment of ruptured aneurysmsH-M Liu, H-F Wong, K-W Lee, et al.
Oncoimmunology|November 3, 2018
Tumor mutational burden is a determinant of immune-mediated survival in breast cancerAlexandra Thomas, Eric D Routh, Ashok Pullikuth, et al.
The Pharmacogenomics Journal|August 3, 2010
Genomic indicators in the blood predict drug-induced liver injuryJ Huang, W Shi, J Zhang, et al.
Scientific Reports|July 14, 2017
Next Generation Driver for Attosecond and Laser-plasma PhysicsD E Rivas, A Borot, D E Cardenas, et al.
Kidney International Reports|June 11, 2020
<i>APOL1</i> Kidney-Risk Variants Induce Mitochondrial FissionLijun Ma, Hannah C Ainsworth, James A Snipes, et al.
Pageof 38